Skip to main content
Top
Published in: Cancer Causes & Control 2/2024

13-09-2023 | Mammography | Original Paper

Latent pathway-based Bayesian models to identify intervenable factors of racial disparities in breast cancer stage at diagnosis

Authors: Inkoo Lee, Yi Luo, Henry Carretta, Gabrielle LeBlanc, Debajyoti Sinha, George Rust

Published in: Cancer Causes & Control | Issue 2/2024

Login to get access

Abstract

Purpose

We built Bayesian Network (BN) models to explain roles of different patient-specific factors affecting racial differences in breast cancer stage at diagnosis, and to identify healthcare related factors that can be intervened to reduce racial health disparities.

Methods

We studied women age 67–74 with initial diagnosis of breast cancer during 2006–2014 in the National Cancer Institute’s SEER-Medicare dataset. Our models included four measured variables (tumor grade, hormone receptor status, screening utilization and biopsy delay) expressed through two latent pathways-a tumor biology path, and health-care access/utilization path. We used various Bayesian model assessment tools to evaluate these two latent pathways as well as each of the four measured variables in explaining racial disparities in stage-at-diagnosis.

Results

Among 3,010 Black non-Hispanic (NH) and 30,310 White NH breast cancer patients, respectively 70.2% vs 76.9% were initially diagnosed at local stage, 25.3% vs 20.3% with regional stage, and 4.56% vs 2.80% with distant stage-at-diagnosis. Overall, BN performed approximately 4.7 times better than Classification And Regression Tree (CART) (Breiman L, Friedman JH, Stone CJ, Olshen RA. Classification and regression trees. CRC press; 1984) in predicting stage-at-diagnosis. The utilization of screening mammography is the most prominent contributor to the accuracy of the BN model. Hormone receptor (HR) status and tumor grade are useful for explaining racial disparity in stage-at diagnosis, while log-delay in biopsy impeded good prediction.

Conclusions

Mammography utilization had a significant effect on racial differences in breast cancer stage-at-diagnosis, while tumor biology factors had less impact. Biopsy delay also aided in predicting local and regional stages-at-diagnosis for Black NH women but not for white NH women.
Appendix
Available only for authorised users
Literature
2.
go back to reference Ren JX, Gong Y, Ling H, Hu X, Shao ZM (2019) Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics. Breast Cancer Res Treat 173(1):225–237CrossRefPubMed Ren JX, Gong Y, Ling H, Hu X, Shao ZM (2019) Racial/ethnic differences in the outcomes of patients with metastatic breast cancer: contributions of demographic, socioeconomic, tumor and metastatic characteristics. Breast Cancer Res Treat 173(1):225–237CrossRefPubMed
3.
go back to reference Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB (2005) Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care 43:141–148CrossRefPubMed Elmore JG, Nakano CY, Linden HM, Reisch LM, Ayanian JZ, Larson EB (2005) Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care 43:141–148CrossRefPubMed
4.
go back to reference Ng AY, Jordan MI (2002) On discriminative vs. generative classifiers: a comparison of logistic regression and Naive Bayes, NIPS; pp 841–848. Ng AY, Jordan MI (2002) On discriminative vs. generative classifiers: a comparison of logistic regression and Naive Bayes, NIPS; pp 841–848.
5.
go back to reference Chen F (2009) SAS Global Forum 2009. Inc SI (ed.). SAS Institute Inc.: Cary Chen F (2009) SAS Global Forum 2009. Inc SI (ed.). SAS Institute Inc.: Cary
6.
go back to reference SAS Institute In 2009(. The MCMC Procedure, SAS/STAT Help Documentation. SAS Institute Inc.: Cary SAS Institute In 2009(. The MCMC Procedure, SAS/STAT Help Documentation. SAS Institute Inc.: Cary
7.
go back to reference Yegnanarayana B (2009) Artificial neural networks. PHI Learning Pvt. Ltd Yegnanarayana B (2009) Artificial neural networks. PHI Learning Pvt. Ltd
8.
go back to reference Hastie T ( 2001) (The elements of statistical learning : data mining, inference, and prediction : with 200 full-color illustrations. Tibshirani, Robert., Friedman, J. H. (Jerome H.).: Springer, New York Hastie T ( 2001) (The elements of statistical learning : data mining, inference, and prediction : with 200 full-color illustrations. Tibshirani, Robert., Friedman, J. H. (Jerome H.).: Springer, New York
9.
go back to reference Tsangaratos P, Ilia I (2016) Comparison of a logistic regression and Naïve Bayes classifier in landslide susceptibility assessments: The influence of models complexity and training dataset size. CATENA 145:164–179CrossRef Tsangaratos P, Ilia I (2016) Comparison of a logistic regression and Naïve Bayes classifier in landslide susceptibility assessments: The influence of models complexity and training dataset size. CATENA 145:164–179CrossRef
10.
go back to reference Miao M, Zeng H, Wang A, Zhao C, Liu F (2017) Discriminative spatial-frequency-temporal feature extraction and classification of motor imagery EEG: An sparse regression and Weighted Naïve Bayesian Classifier-based approach. J Neurosci Methods 278:13–24CrossRefPubMed Miao M, Zeng H, Wang A, Zhao C, Liu F (2017) Discriminative spatial-frequency-temporal feature extraction and classification of motor imagery EEG: An sparse regression and Weighted Naïve Bayesian Classifier-based approach. J Neurosci Methods 278:13–24CrossRefPubMed
14.
go back to reference Oeffinger KC, Fontham ETH, Etzioni R et al (2015) Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 314(15):1599–1614CrossRefPubMedPubMedCentral Oeffinger KC, Fontham ETH, Etzioni R et al (2015) Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA 314(15):1599–1614CrossRefPubMedPubMedCentral
15.
go back to reference Young JL (2001) SEER summary staging manual 2000: codes and coding instructions (No. 1). National Cancer Institute, National Institutes of Health Young JL (2001) SEER summary staging manual 2000: codes and coding instructions (No. 1). National Cancer Institute, National Institutes of Health
16.
go back to reference Merkin SS, Stevenson L, Powe N (2002) Geographic socioeconomic status, race, and advanced-stage breast cancer in New York City. Am J Public Health 92(1):64–70CrossRefPubMedPubMedCentral Merkin SS, Stevenson L, Powe N (2002) Geographic socioeconomic status, race, and advanced-stage breast cancer in New York City. Am J Public Health 92(1):64–70CrossRefPubMedPubMedCentral
17.
go back to reference Garland SN, Johnson B, Palmer C et al (2014) Physical activity and telomere length in early stage breast cancer survivors. Breast Cancer Res 16(4):1–9CrossRef Garland SN, Johnson B, Palmer C et al (2014) Physical activity and telomere length in early stage breast cancer survivors. Breast Cancer Res 16(4):1–9CrossRef
20.
go back to reference Randolph WM, Mahnken JD, Goodwin JS, Freeman JL (2002) Using Medicare data to estimate the prevalence of breast cancer screening in older women: comparison of different methods to identify screening mammograms. Health Serv Res 37(6):1643–1657CrossRefPubMedPubMedCentral Randolph WM, Mahnken JD, Goodwin JS, Freeman JL (2002) Using Medicare data to estimate the prevalence of breast cancer screening in older women: comparison of different methods to identify screening mammograms. Health Serv Res 37(6):1643–1657CrossRefPubMedPubMedCentral
21.
go back to reference Selove R, Kilbourne B, Fadden MK et al (2016) Time from screening mammography to biopsy and from biopsy to breast cancer treatment among black and white, women Medicare beneficiaries not participating in a health maintenance organization. Womens Health Issues 26(6):642–647CrossRefPubMedPubMedCentral Selove R, Kilbourne B, Fadden MK et al (2016) Time from screening mammography to biopsy and from biopsy to breast cancer treatment among black and white, women Medicare beneficiaries not participating in a health maintenance organization. Womens Health Issues 26(6):642–647CrossRefPubMedPubMedCentral
22.
go back to reference Fiscella K, Holt K, Meldrum S, Franks P (2006) Disparities in preventive procedures: comparisons of self-report and Medicare claims data. BMC Health Serv Res 6(1):122CrossRefPubMedPubMedCentral Fiscella K, Holt K, Meldrum S, Franks P (2006) Disparities in preventive procedures: comparisons of self-report and Medicare claims data. BMC Health Serv Res 6(1):122CrossRefPubMedPubMedCentral
25.
go back to reference Mulaik WM (2014) Coding for percutaneous breast procedures. Radiology Today 15(8):10 Mulaik WM (2014) Coding for percutaneous breast procedures. Radiology Today 15(8):10
26.
go back to reference Billing and Coding: Tomosynthesis-Guided Breast Biopsy (A57848). 2020: 2019 American Medical Association. Billing and Coding: Tomosynthesis-Guided Breast Biopsy (A57848). 2020: 2019 American Medical Association.
27.
go back to reference Freeman JL, Klabunde CN, Schussler N, Warren JL, Virnig BA, Cooper GS (2002) Measuring breast, colorectal, and prostate cancer screening with Medicare claims data. Med Care 40:36–42CrossRef Freeman JL, Klabunde CN, Schussler N, Warren JL, Virnig BA, Cooper GS (2002) Measuring breast, colorectal, and prostate cancer screening with Medicare claims data. Med Care 40:36–42CrossRef
28.
go back to reference Vyas A, Madhavan S, Sambamoorthi U (2014) Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancer. Breast Cancer Res Treat 148(3):645–654CrossRefPubMedPubMedCentral Vyas A, Madhavan S, Sambamoorthi U (2014) Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancer. Breast Cancer Res Treat 148(3):645–654CrossRefPubMedPubMedCentral
29.
go back to reference Fenton JJ, Zhu W, Balch S, Smith-Bindman R, Fishman P, Hubbard RA (2014) Distinguishing screening from diagnostic mammograms using Medicare claims data. Med care 52(7):e44CrossRefPubMedPubMedCentral Fenton JJ, Zhu W, Balch S, Smith-Bindman R, Fishman P, Hubbard RA (2014) Distinguishing screening from diagnostic mammograms using Medicare claims data. Med care 52(7):e44CrossRefPubMedPubMedCentral
30.
go back to reference Kendall MG, Gibbons JD (1990) Rank correlation methods: charles griffin book series, 5th edn. Oxford University Press, Oxford Kendall MG, Gibbons JD (1990) Rank correlation methods: charles griffin book series, 5th edn. Oxford University Press, Oxford
31.
go back to reference Friedman N, Geiger D, Goldszmidt M (1997) Bayesian network classifiers. Mach Learn 29(2–3):131–163CrossRef Friedman N, Geiger D, Goldszmidt M (1997) Bayesian network classifiers. Mach Learn 29(2–3):131–163CrossRef
32.
go back to reference Hastings WK (1970) Monte-Carlo sampling methods using Markov chains and their applications. Biometrika 57:97–109CrossRef Hastings WK (1970) Monte-Carlo sampling methods using Markov chains and their applications. Biometrika 57:97–109CrossRef
33.
go back to reference Roger E (1987) Stan Ulam, John Von Neumann, and the Monte Carlo method. Argonne 15:131–137 Roger E (1987) Stan Ulam, John Von Neumann, and the Monte Carlo method. Argonne 15:131–137
34.
go back to reference Gelman A, Carlin JB, Stern HS, Dunson DB, Vehtari A, Rubin DB (2014) Bayesian data analysis, 3rd edn. CRC Press, Boca Raton Gelman A, Carlin JB, Stern HS, Dunson DB, Vehtari A, Rubin DB (2014) Bayesian data analysis, 3rd edn. CRC Press, Boca Raton
35.
go back to reference Ibrahim JG, Chen MH, Sinha D (2001) Bayesian survival analysis. Springer, New YorkCrossRef Ibrahim JG, Chen MH, Sinha D (2001) Bayesian survival analysis. Springer, New YorkCrossRef
36.
go back to reference Bazila BA (2018) Thirumalaikolundusubramanian P. Comparison of Bayes classifiers for breast cancer classification. Asian Pac J Cancer Prev 19(10):2917 Bazila BA (2018) Thirumalaikolundusubramanian P. Comparison of Bayes classifiers for breast cancer classification. Asian Pac J Cancer Prev 19(10):2917
37.
go back to reference Kass RE, Raftery AE (1995) Bayes factors. J Am Stat Assoc 90(430):773–795CrossRef Kass RE, Raftery AE (1995) Bayes factors. J Am Stat Assoc 90(430):773–795CrossRef
38.
go back to reference Breiman L, Friedman JH, Stone CJ, Olshen RA (1984) Classification and regression trees. CRC Press, Boston Breiman L, Friedman JH, Stone CJ, Olshen RA (1984) Classification and regression trees. CRC Press, Boston
39.
go back to reference Brant R (1990) Assessing proportionality in the proportional odds model for ordinal logistic regression. Biometrics 46(4):1171–1178CrossRefPubMed Brant R (1990) Assessing proportionality in the proportional odds model for ordinal logistic regression. Biometrics 46(4):1171–1178CrossRefPubMed
41.
go back to reference Chiarelli AM, Muradali D, Blackmore KM et al (2017) Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care. Br J Cancer 116(10):1254–1263CrossRefPubMedPubMedCentral Chiarelli AM, Muradali D, Blackmore KM et al (2017) Evaluating wait times from screening to breast cancer diagnosis among women undergoing organised assessment vs usual care. Br J Cancer 116(10):1254–1263CrossRefPubMedPubMedCentral
42.
go back to reference Olivotto IA, Gomi A, Bancej C et al (2002) Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 94(8):2143–2150CrossRefPubMed Olivotto IA, Gomi A, Bancej C et al (2002) Influence of delay to diagnosis on prognostic indicators of screen-detected breast carcinoma. Cancer 94(8):2143–2150CrossRefPubMed
52.
go back to reference Njai R, Siegel PZ, Miller JW, Liao Y (2011) Misclassification of survey responses and black-white disparity in mammography use, Behavioral Risk Factor Surveillance System, 1995–2006. Prev Chronic Dis 8(3):A59PubMedPubMedCentral Njai R, Siegel PZ, Miller JW, Liao Y (2011) Misclassification of survey responses and black-white disparity in mammography use, Behavioral Risk Factor Surveillance System, 1995–2006. Prev Chronic Dis 8(3):A59PubMedPubMedCentral
Metadata
Title
Latent pathway-based Bayesian models to identify intervenable factors of racial disparities in breast cancer stage at diagnosis
Authors
Inkoo Lee
Yi Luo
Henry Carretta
Gabrielle LeBlanc
Debajyoti Sinha
George Rust
Publication date
13-09-2023
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 2/2024
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-023-01785-w

Other articles of this Issue 2/2024

Cancer Causes & Control 2/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine